Healthcare & Pharmaceuticals

Three new diabetes drugs have recently taken the world by storm: Ozempic, Mounjaro and Wegovy – because they also help users lose weight. But in recent months over 50 lawsuits have been filed against Eli Lilly and Novo Nordisk, the drug makers, for alleged side effects such as stomach paralysis. Read More

John Durnell was diagnosed with cancer after using the Roundup weedkiller for over 20 years. He sued Roundup manufacturer Monsanto in St. Louis, Missouri. Read More

Health insurance giant Cigna has been sued for using a secret computer algorithm to systematically deny thousands of medical reimbursement claims in a matter of seconds, allegedly without a doctor ever opening the patients’ files. The algorithm was first uncovered by investigative reporters at ProPublica and The Capitol Forum. Read More

Big pharmaceutical companies like Johnson & Johnson and Pfizer signed lucrative contracts with governments around the world to provide COVID-19 vaccines under the condition that the prices and contract terms were kept confidential. Health Justice Initiative, a South African NGO, won a lawsuit in the Pretoria High Court to make the documents public. Read More

“Fue una tragedia, una autentica tragedia”, dijo a CorpWatch José Luiz García, cuya tía fue una de las pocas personas que sobrevivieron al brote de COVID-19 en una residencia DomusVi en Alcoi, España. “Esto es el índice de fallecimientos en porcentaje que nosotros tenemos conocimiento más alto en toda Europa”. Read More

“It was a tragedy, a real tragedy,” José Luiz Garcia, whose aunt was one of the few that survived the COVID-19 outbreak at a DomusVi care home in Alcoi, Spain, told CorpWatch. “This is the highest rate of deaths that we are aware of in all of Europe.” Read More

Eli Lilly charges U.S. customers up to $300 a dose for insulin despite the fact that its production costs are around $10. Unlike most other countries, the U.S. refuses to regulate Big Pharma’s ‘market’ prices. Following a decade of protests, Eli Lilly bowed to pressure and capped U.S. prices at $35 a dose. Read More

COVID-19 mortality rates at eldercare homes in Madrid managed by private companies DomusVi and Orpea were close to double that of eldercare homes in public hands during the first wave of the pandemic, as illustrated in a new map published by CorpWatch. Read More

CorpWatch is publishing a guide to over a dozen of the worst companies profiting from healthcare privatization in Europe. Workers are being paid less, clinics are being shut, and worse yet: people's health is suffering and death rates are increasing to line the pockets of investors and top managers. Read More

La tasa de mortalidad por covid-19 en las residencias de mayores de Madrid gestionadas por las empresas privadas DomusVi y Orpea durante la primera ola de la pandemia fue casi el doble de la tasa en las residencias de mayores de titularidad pública, ilustrado en un nuevo mapa publicado por CorpWatch. Read More